Exchange: NASDAQ·Updated 07:40 PM EST
SLXN logo

SLXN Silexion Therapeutics Ltd

$1.25
$0.19
(12.67%)
Today
Closed $1.31
$0.06
(4.58%)
After Hours
Reported EarningsNov 13
Mkt Cap$850,882.00
Vol16,451.00

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
42

Bearish Sentiment

How do you feel about SLXN?

Rayvio_News_Filter
$SLXN 🏥 Silexion Therapeutics announced the first patient dosed in the Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer at Tel Aviv Sourasky Medical Center, advancing SIL204 into active patient treatment. Curated for market relevance
ReversalRuler
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $SLXN $GOVX $NCI $JOB ..
Lyn30
$SLXN 634k float post split Post split most of the time volume/ holder vs shorts and it’s a best guess game to make max profit imo. So my guess it may be the winner like drug imo
aaaaaa99
$SLXN I seriously hope NASDAQ stops giving this company a pass and just delists them already. At this point, I’d rather just see a delisting pump so we can get some kind of exit rally.

Advertisement|Remove ads.